ATC level 4
J05APDirect acting antiviral, subgroup J05AP
- Molecules
- 7
- Subgroups
- 7
ATC J05AP (Direct acting antiviral, subgroup J05AP) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 7 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J05AP.
- Elbasvir and GrazoprevirHepatitis C Virus NS3/4A Protease Inhibitor1 presentation1 brandJ05AP54
- Glecaprevir and PibrentasvirOrphanHepatitis C Virus NS3/4A Protease Inhibitor2 presentations2 brandsJ05AP57
- Ledipasvir and SofosbuvirOrphanHepatitis C Virus NS5A Inhibitor5 presentations1 brandJ05AP51
- RibavirinOrphanNucleoside Analog3 presentationsJ05AB04
- SofosbuvirOrphanHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor4 presentations2 brandsJ05AP08
- Sofosbuvir and VelpatasvirOrphanHepatitis C Virus NS5A Inhibitor5 presentations2 brandsJ05AP55
- Sofosbuvir, Velpatasvir and VoxilaprevirHepatitis C Virus NS3/4A Protease Inhibitor1 presentation1 brandJ05AP56
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.